» Articles » PMID: 39220912

Integrating Network Analysis and Experimental Validation to Reveal the Mechanism of Si-jun-zi Decoction in the Treatment of Renal Fibrosis

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Sep 2
PMID 39220912
Authors
Affiliations
Soon will be listed here.
Abstract

Treating kidney diseases from the perspective of spleen is an important clinical method in traditional Chinese medicine (TCM) for anti-renal fibrosis (RF). Si-jun-zi decoction (SJZD), a classic formula for qi-invigorating and spleen-invigorating, has been reported to alleviate RF. This study aims to investigate the potential mechanism by which SJZD attenuates RF. The results demonstrated notable improvements in renal function levels, inflammation and fibrosis indices in UUO-mice following SJZD intervention. The main active ingredients identified were Quercetin, Kaempferol, Naringenin and 7-Methoxy-2-methyl isoflavone. Furthermore, STAT3, MAPK3, MYC were confirmed as key targets. Additionally, GO enrichment analysis demonstrated that SJZD delayed RF primarily by regulating oxidative stress and other biological mechanisms. KEGG enrichment analysis revealed the involvement of pathways such as Lipid and atherosclerosis signaling pathway, MAPK signaling pathway and other pathways in the reno-protective effects of SJZD. The molecular docking results revealed that the active ingredients of SJZD were well-bound and stable to the core targets. The experiments results revealed that Quercetin, Kaempferol, and Naringenin not only improved the morphology of TGF-β-induced HK-2 cells but also reversed the expression of α-SMA, COL1A1 and MAPK, thereby delaying the progression of RF. The anti-RF effects of SJZD were exerted through multi-components, multi-targets and multi-pathways.

References
1.
Kurtzeborn K, Kwon H, Kuure S . MAPK/ERK Signaling in Regulation of Renal Differentiation. Int J Mol Sci. 2019; 20(7). PMC: 6479953. DOI: 10.3390/ijms20071779. View

2.
Chen Y, Chen H, Tang Q, Li Y, Liu X, Lu F . Protective effect of quercetin on kidney diseases: From chemistry to herbal medicines. Front Pharmacol. 2022; 13:968226. PMC: 9478191. DOI: 10.3389/fphar.2022.968226. View

3.
Asgharzadeh F, Bargi R, Hosseini M, Farzadnia M, Khazaei M . Cardiac and renal fibrosis and oxidative stress balance in lipopolysaccharide-induced inflammation in male rats. ARYA Atheroscler. 2018; 14(2):71-77. PMC: 6087628. DOI: 10.22122/arya.v14i2.1550. View

4.
Wang M, Chen D, Chen L, Liu D, Zhao H, Zhang Z . Novel RAS Inhibitors Poricoic Acid ZG and Poricoic Acid ZH Attenuate Renal Fibrosis via a Wnt/β-Catenin Pathway and Targeted Phosphorylation of smad3 Signaling. J Agric Food Chem. 2018; 66(8):1828-1842. DOI: 10.1021/acs.jafc.8b00099. View

5.
Sanchez-Jaramillo E, Gasca-Lozano L, Vera-Cruz J, Hernandez-Ortega L, Gurrola-Diaz C, Bastidas-Ramirez B . Nanoparticles Formulation Improves the Antifibrogenic Effect of Quercetin on an Adenine-Induced Model of Chronic Kidney Disease. Int J Mol Sci. 2022; 23(10). PMC: 9140764. DOI: 10.3390/ijms23105392. View